AGER and Alzheimer disease: In the current model of AD, ICV-STZ injection resulted in a significant upregulation of RAGE and a down-regulation of ABCA1 and LRP1, which regulate Aβ influx and clearance, respectively, and would favor Aβ accumulation within brain tissue in AD.